What is Embryo Banking?
Science is giving women more and more choices for family building. With recent advances in assisted reproductive technologies, women can now […]

Cytoplasmic transfer (CT) in vitro fertilisation is an advanced fertility method designed to help women with low-quality eggs improve their chances of getting pregnant. During this procedure, a small amount of cytoplasm from a healthy, young donor egg is added to the recipient’s egg during the intracytoplasmic sperm injection (ICSI) process. This technique has been known to increase fertilisation rates significantly, from 53.5% to 67%. It also helps eliminate the adverse effects of ageing on egg quality, making it a promising option for older women.
CT not only boosts fertilisation rates but also improves the quality of embryos, resulting in a higher proportion of high-quality embryos produced compared to traditional methods. The success of this procedure is mainly due to the transfer of healthy mitochondria from the donor egg, which provides the energy needed for the embryo to develop properly. Overall, cytoplasmic transfer offers a promising alternative for women seeking to increase their chances of having a baby using their eggs during an embryo transfer.
Important Note: Although cytoplasmic transfer is discussed here, Dunya IVF centre does not currently offer this procedure. Cytoplasmic transfer remains an experimental technique with limited evidence and is not part of mainstream fertility treatments. Current scientific data are not sufficient to guarantee its safety or effectiveness, and it should not be viewed as a solution to all fertility problems. This article aims only to inform.
Cytoplasmic transfer is a new approach used alongside IVF treatments. While it isn’t a standalone treatment, it helps women facing infertility issues caused by weak or damaged mitochondria in their eggs. As we age, our cells, including those in our eggs, can lose their ability to function optimally.
Mitochondria, located in the cytoplasm of egg cells, play a crucial role in producing energy, facilitating cell division, and supporting cellular growth. When mitochondria are not functioning properly, it can cause problems such as unsuccessful embryo implantation and increased embryo fragmentation, leading to poor embryo development and potentially a failed IVF cycle.
In 2021, a groundbreaking technique known as cytotransfer was discovered to enhance the quality of eggs in women experiencing low ovarian function. This includes those facing challenges due to older age, limited ovarian reserve, or an insufficient response to stimulation, and it has proven effective regardless of the woman’s age. After undergoing cytotransfer, many patients experienced improved fertilisation rates and better early embryo growth. These improvements may be linked to the positive effects on the cytoplasm of the eggs, which various studies have supported. However, further research on human subjects is needed to explore the molecular benefits of this technique in greater detail and to confirm its safety for future use.
Additionally, cytotransfer has shown success in helping women who have had trouble with implantation in the past, regardless of whether their embryos developed poorly.
One of the standout benefits of this innovative method is its practicality. The donor’s cytoplasm can be introduced into the patient’s egg right alongside the sperm during an Intracytoplasmic Sperm Injection (ICSI) procedure. This integration enables it to become part of standard practices in IVF labs, making it accessible to embryologists everywhere.
Cytoplasmic transfer can boost fertilisation rates during IVF treatments. It may also enhance embryo development, increasing the chances of successful implantation. This technique involves adding healthy cytoplasm to the recipient’s fertilised egg, aiming to improve its overall quality and potential for development.
In certain instances, this approach has demonstrated potential in supporting women who have experienced multiple implantation failures or challenges with embryo development in their journey to conception. It’s important to recognise the emotional and physical toll that these struggles can take, and finding hope in such methods can be a light for many aspiring parents.
Cytoplasmic transfer (CT) is a technique that can help women struggling with egg quality, particularly those over 35 or those who have faced repeated challenges with IVF or miscarriages. By using cytoplasm from a younger woman’s egg, this method offers a way to improve the health of embryos. The healthy cytoplasm includes vital components like mitochondria, which may promote the chances of a successful pregnancy. This process holds hope for many women seeking to start or grow their families.
Women who have poor egg quality can face challenges, even if they are young. There are many reasons this can happen. For these women, using a procedure like CT can be a helpful choice to improve their chances of getting pregnant and having healthy embryos.
For couples who have gone through several unsuccessful IVF attempts or have faced repeated miscarriages, one common concern might be the quality of the eggs. This can make the journey to pregnancy feel even more challenging. However, considering a treatment like CT could offer hope and improve the chances of a successful pregnancy. It’s crucial to explore all options and find the right path together, as each journey is unique and deserves compassionate support.
Some couples might decide not to use donor eggs because of personal choices or beliefs. For these women, it’s important to use their own eggs. Fortunately, with specific treatments, they can still enjoy better egg quality, making their journey a little easier and more hopeful.
Infertility treatment is not uncommon these days for some reasons. Advanced maternal age, birth defects, and other unfortunate events are caused mainly by lower education and income, and older age, among others.
With the emergence of cytoplasmic transfer, couples can now be helped in improving embryo quality. But it should be noted that CT should not be treated as a certain solution for infertility. Still, the best way for successful treatments is to consult healthcare providers who specialise in this medical treatment.
When it comes to helping couples conceive, aside from intrauterine insemination, other assisted reproductive technologies are in vitro fertilisation (IVF), cytoplasmic transfer, and intracytoplasmic sperm injection (ICSI).
In the case of traditional IVF, the eggs and sperm are placed together in a laboratory dish, where they naturally come together and fertilise.
Cytoplasmic transfer is used to enhance fertilisation and egg quality for women. Typically, the egg’s cytoplasm is derived from women who are younger and more fertile.
On the other hand, assisted reproduction through ICSI takes a more straightforward approach by means of direct injection – injecting a single sperm straight into the egg, making it a good option for specific challenges.
Each method has its own place, and understanding these differences can help you make informed choices on your journey to parenthood.
Cytoplasmic transfer (CT) is a complex procedure with various ethical and regulatory standards. It’s worth noting the key considerations for better knowledge of the procedure.
Hereditary Genetic Changes: Cytoplasmic transfer involves the direct introduction of donor mitochondria carrying genetic material into a woman’s egg cell. This process creates lasting changes that travel through family lines, since these cellular additions become part of what parents pass to their children for generations ahead.
Unknown Future Health Impacts: Scientists cannot predict how this treatment will affect a child’s well-being years or decades later. Medical research lacks the depth needed to understand what happens when children grow up with mixed mitochondrial genetics from multiple sources.
Risk of Patient Vulnerability: High treatment costs, combined with inadequate oversight in some medical facilities, create dangerous situations. Desperate families hoping for pregnancy may face pressure to undergo procedures without proper safeguards or honest discussions about success rates.
Clear Communication and Personal Choice: Doctors must help patients truly grasp both the promising possibilities and serious unknowns before moving forward. People deserve honest conversations about how this treatment might reshape their family’s genetic future before making such profound decisions.
Now that we know cytoplasm transfer as an assisted reproductive technology, isn’t it great to learn more about this intricate technique and how it works? Let’s look at them one by one:
Doctors need a healthy egg from a younger woman, usually between 24 and 32 years old. The donor goes through careful health checks to make sure she doesn’t have genetic problems, hormone issues, or infections.
The doctor uses a tiny, thin needle to collect the sperm, just like in regular IVF treatment.
Next, the doctor uses the same needle to take out a small amount of the “inside stuff” (called cytoplasm) from the donor egg – about 10-15% of it. They’re careful to take this material from the part of the egg that’s furthest away from a small structure called the polar body.
The doctor then injects both the sperm and the donor material into the patient’s egg using the same method as regular IVF. The sperm acts like a signal to show when the transfer is complete.
This process moves tiny energy-producing parts called mitochondria, along with other small cell components and helpful substances, from the young donor egg into the older patient’s egg.
The goal is to provide the patient’s egg with more and better mitochondria, thereby increasing its energy. This extra energy helps with important tasks, such as cleaning up the sperm’s own genetic material, forming the structures needed for cell division, and facilitating the early embryo’s proper growth. While this can’t fix existing genetic problems, it gives the egg a better chance of working well.
One donor egg can provide enough material to help 4-5 patients.
This treatment helps older women’s eggs function more effectively and can improve the chances of a successful pregnancy, as egg quality typically declines with age.
As in most cases of assisted reproductive technology, the joy of parenthood is priceless. And that is the aim of most IVF clinics: to fulfil their dreams of becoming parents to healthy babies. As complex as it may seem, these clinics are dedicated to helping you achieve pregnancy.
Cytoplasmic transfer offers hope to women whose eggs need a little extra help to create healthy babies. Think of it as giving your eggs a boost of energy and vitality from younger, healthier eggs. This treatment focuses on fixing problems inside the egg that can make it harder to get pregnant and carry a baby to term.
The cytoplasmic transfer cost varies for most IVF clinics. The reason is that the cost structure accounts for the technical expertise, additional quality control measures, and the specialised nature of this procedure.
As women grow older, especially after age 35, their eggs naturally become less energetic and healthy. It’s like a car battery that slowly loses its power over time – the engine (your egg) is still good, but it doesn’t have enough energy to start properly.
Inside every egg are tiny powerhouses called mitochondria – think of them as the egg’s battery pack. These little energy makers can develop problems ten times faster than other parts of the egg. When this happens:
This energy shortage can affect critical moments like when the sperm and egg first meet, when chromosomes need to line up correctly, and when the early embryo tries to grow and divide.
The solution is simple yet scientifically advanced. During your IVF treatment, doctors carefully take a small amount of healthy material (about 10–15%) from a thoroughly screened egg donor between the ages of 24 and 32.
This healthy material contains:
Your doctor combines this energy-rich material with your partner’s sperm and gently places both into your own egg. Your genetic material – your DNA – remains completely yours. You’re simply giving your egg the energy boost it needs to do its job better.
Women who receive this treatment often see encouraging improvements:
The treatment helps prevent new chromosomal problems from developing during the crucial early stages, though it can’t fix existing genetic issues. A healthy environment provides your genetic material with the best possible chance to combine correctly and develop normally.
It’s important to know that all eggs naturally contain a mix of healthy and slightly damaged mitochondria – this is completely normal. The small amount of donor material added to your egg creates a situation that’s very similar to what happens naturally.
Nearly 30 healthy babies have been born worldwide using this technique, with no health problems related to the treatment. The donor mitochondria are carefully screened, and the amount transferred is so small that it typically doesn’t affect your baby’s characteristics or health.
The donor material only provides energy production – it doesn’t change your baby’s appearance, personality, or inherited traits. Your child will still be completely yours genetically, just with the added energy boost that helped them develop properly from the very beginning.
This treatment represents the beautiful intersection of cutting-edge science and the timeless dream of parenthood. While researchers continue to learn more about how eggs work and develop, cytoplasmic transfer offers real hope today for women who have been struggling to conceive.
Remember, this treatment is designed to give your eggs the best possible chance to succeed. It’s not replacing anything that makes you uniquely you – it’s simply providing the energy and support your eggs need to help bring your dreams of parenthood to life.
When favourable genetic material is combined with healthy cytoplasm, it can yield positive outcomes. In a study using cytoplasmic transfer (CT), a fertilisation rate of 67.2% was observed. After transferring the embryos created with CT, the pregnancy rate was 25.9%, and the percentage of babies taken home was 18.2%.